Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

FWIW, I found this on the Global BioPharma website. The bolded parts here are also in bold on the website:

Lung Caner (sic)
"In China, Taiwan and around the world, lung cancer deaths are the main reason. At present, China is the world's first lung power, if not effectively controlled, lung cancer patients in China is expected to reach one million in 2025. Since China and Taiwan lung cancer patients are HPV (+) ratio is relatively higher than other countries. GBP will be a priority in this year's independent development ADXS-HPV vaccine to treat HPV (+) patients with lung cancer."

Cervical Cancer
"Cervical cancer is the second most common cancer, only next to breast cancer, of women. Asian race each year with the number of cervical cancer is much greater than in Western World. At present, in addition to radiotherapy, outside the surgery, is the traditional chemotherapy. ADXS-HPV vaccine may be found in patients with advanced providing effective immunotherapy. GBP and Advaxis plans to execute the multi-center treatment of cervical cancer advanced Phase III clinical trials in 2014. GBP will continue to develop in Asia with Advaxis ADXS-HPV vaccine to treat head and neck cancer, anal cancer."